FDA Approved: XYZAL — Original Application (Chattem, Inc.)

View source ↗

Summary

The FDA approved the original application for XYZAL (levocetirizine dihydrochloride) by Chattem, Inc., for the treatment of allergic rhinitis and chronic idiopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)